This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $250 | Check With Us |
500mg | $480 | Check With Us |
1g | $720 | Check With Us |
Cat #: V1853 CAS #: 293754-55-9 Purity ≥ 98%
Description: T0901317 (formerly known as T-1317 or TO-091317 or TO 901317) is a potent and selective liver X receptor (LXR) agonist for multiple targets, which has EC50 values of 20 nM and 5 μM for LXRα and FXR, respectively.
References: J R Schultz, et al. Role of LXRs in Control of Lipogenesis. Genes Dev. 2000 Nov 15;14(22):2831-8.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 481.33 |
---|---|
Molecular Formula | C17H12F9NO3S |
CAS No. | 293754-55-9 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 96 mg/mL (199.4 mM)r |
Water: <1 mg/mLr | |
Ethanol: 96 mg/mL (199.4 mM) | |
SMILES Code | OC(C(F)(F)F)(C(F)(F)F)C1=CC=C(N(CC(F)(F)F)S(C2=CC=CC=C2)(=O)=O)C=C1 |
Synonyms | TO-91317; TO 901317; TO 901317; TO-091317; TO 091317; TO091317; T-0901317; T0901317; T 0901317; T-1317; T1317; T 1317; |
Protocol | In Vitro | T0901317 (5-50 μM; 72 hours) significantly inhibits cellular proliferation in CaOV3, SKOV3, A2780 (human ovarian carcinoma cell lines) in a dose-dependent and time-dependent manner. |
---|---|---|
In Vivo | T0901317 (10 mg/kg/day; orally; for 12 weeks) inhibits the progression of atherosclerosis. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.0776 mL | 10.3879 mL | 20.7758 mL | 41.5515 mL |
5mM | 0.4155 mL | 2.0776 mL | 4.1552 mL | 8.3103 mL |
10mM | 0.2078 mL | 1.0388 mL | 2.0776 mL | 4.1552 mL |
20mM | 0.1039 mL | 0.5194 mL | 1.0388 mL | 2.0776 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.